Bluebird Bio Company
bluebird bio, Inc., based in Cambridge, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders and cancer
Industry:
Stem Cell Exhaustion
Technology:
Genetic Test & Molecular Diagnostics
Funding Status:
IPO
Investment Stage:
N/A
Estimated Revenue:
$10M to $50M
Investors Number:
13
Headquarters:
United Kingdom
Employee Number:
501-1000
Number Of Exists:
N/A
Investor Type:
N/A
Total Funding:
409000000 USD
Founded Date:
01.01.1993
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2016-12-07